Please wait
0001484565EX-FILING FEESfalse 0001484565 2025-02-28 2025-02-28 0001484565 1 2025-02-28 2025-02-28 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
CALCULATION OF REGISTRATION FEE TABLES
Form
S-8
(Form Type)
Soleno Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
Table 1 – Newly Registered Securities
 
               
Security Type   Securities Class Type   Fee
 Calculation 
Rule
 
Amount
to be
Registered
(1)
  Proposed
Maximum
Offering Price
Per Share
 
Proposed
Maximum Aggregate
Offering Price
  Fee Rate   Amount of
Registration
Fee
               
Equity   Common Stock $0.001 par value, reserved for issuance pursuant to Amended and Restated 2014 Equity Incentive Plan  
Rules 457(c)
and (h)
 
1,828,152 shares
(2)
  $44.105
 (3)
 
$80,630,643.96
  0.0001531  
$12,344.56
           
TOTAL OFFERING AMOUNT
 
1,828,152
shares
   
$80,630,643.96
    $12,344.56
         
TOTAL FEE OFFSETS
(4)
         
         
NET FEE DUE
              $12,344.56
 
(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement covers any additional shares of the Registrant’s common stock that become issuable under the Registrant’s Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”), by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of outstanding shares of common stock.
(2)
Represents an automatic increase of 1,828,152 shares of the Registrant’s common stock reserved for issuance under, and which annual increase is provided for in, the 2014 Plan and represents 4.0% of the 45,703,811 shares of the Registrant’s outstanding common stock on December 31, 2024.
(3)
Estimated in accordance with Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $44.105 per share, which represents the average of the high and low prices on the common stock as reported on the Nasdaq Capital Market on February 25, 2025.
(4)
The Registrant does not have any fee offsets.